Found 5 matching trials
Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy PHASE3 Primary Objective:
* To demonstrate the superior efficacy (composite of al...
Show More Location
Investigational Site Number 840015
Learn More & Join Trial
Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild, Moderate and Severe Renal Impairment PHASE1 Primary Objective:
* To study effect of mild, moderate and severe renal im...
Show More Location
Investigational Site Number 840003
Learn More & Join Trial
Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild and Moderate Hepatic Impairment PHASE1 Primary Objective:
\- To study effect of mild and moderate hepatic impairm...
Show More Location
Investigational Site Number 840003
Learn More & Join Trial
Study of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary Syndrome PHASE2 Primary objective: To demonstrate the clinical efficacy of otamixaban (dose...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention PHASE2 The objective of this dose-ranging study is to determine the effects of sev...
Show More Location
Los Angeles Cardiology Associates
Learn More & Join Trial